nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—bone cancer	0.446	1	CrCtD
Leucovorin—Pralatrexate—Methotrexate—bone cancer	0.059	0.2	CrCrCtD
Leucovorin—Pemetrexed—Methotrexate—bone cancer	0.059	0.2	CrCrCtD
Leucovorin—Raltitrexed—Methotrexate—bone cancer	0.059	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—bone cancer	0.059	0.2	CrCrCtD
Leucovorin—Folic Acid—Methotrexate—bone cancer	0.059	0.2	CrCrCtD
Leucovorin—TYMS—Methotrexate—bone cancer	0.0478	0.221	CbGbCtD
Leucovorin—ABCC3—Cisplatin—bone cancer	0.0381	0.177	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—bone cancer	0.0256	0.119	CbGbCtD
Leucovorin—ABCC3—Methotrexate—bone cancer	0.0248	0.115	CbGbCtD
Leucovorin—ABCC2—Carboplatin—bone cancer	0.0203	0.0941	CbGbCtD
Leucovorin—ABCC4—Methotrexate—bone cancer	0.0189	0.0877	CbGbCtD
Leucovorin—ABCC2—Cisplatin—bone cancer	0.0173	0.0804	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—bone cancer	0.0116	0.0539	CbGbCtD
Leucovorin—ABCC2—Methotrexate—bone cancer	0.0113	0.0522	CbGbCtD
Leucovorin—TYMS—Pyrimidine metabolism—NT5C3A—bone cancer	0.00148	0.0705	CbGpPWpGaD
Leucovorin—Caecitis—Epirubicin—bone cancer	0.00118	0.059	CcSEcCtD
Leucovorin—Extravasation—Carboplatin—bone cancer	0.00113	0.0563	CcSEcCtD
Leucovorin—Caecitis—Doxorubicin—bone cancer	0.0011	0.0546	CcSEcCtD
Leucovorin—ABCC3—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00102	0.0484	CbGpPWpGaD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000953	0.0453	CbGpPWpGaD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000896	0.0426	CbGpPWpGaD
Leucovorin—Methotrexate—FOLR1—bone cancer	0.000843	0.325	CrCbGaD
Leucovorin—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000807	0.0384	CbGpPWpGaD
Leucovorin—TYMS—G1/S-Specific Transcription—DHFR—bone cancer	0.000794	0.0377	CbGpPWpGaD
Leucovorin—Pralatrexate—DHFR—bone cancer	0.000783	0.301	CrCbGaD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000755	0.0359	CbGpPWpGaD
Leucovorin—Pemetrexed—DHFR—bone cancer	0.000626	0.241	CrCbGaD
Leucovorin—TYMS—Nucleotide metabolism—NT5C3A—bone cancer	0.000577	0.0275	CbGpPWpGaD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000557	0.0265	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000547	0.026	CbGpPWpGaD
Leucovorin—TYMS—One Carbon Metabolism—DHFR—bone cancer	0.000532	0.0253	CbGpPWpGaD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000523	0.0249	CbGpPWpGaD
Leucovorin—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.000516	0.0245	CbGpPWpGaD
Leucovorin—Febrile neutropenia—Cisplatin—bone cancer	0.00048	0.0239	CcSEcCtD
Leucovorin—TYMS—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.000479	0.0228	CbGpPWpGaD
Leucovorin—Serum creatinine increased—Cisplatin—bone cancer	0.00047	0.0234	CcSEcCtD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—DHFR—bone cancer	0.000467	0.0222	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—DHFR—bone cancer	0.000467	0.0222	CbGpPWpGaD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000441	0.021	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000434	0.0206	CbGpPWpGaD
Leucovorin—Sensitisation—Epirubicin—bone cancer	0.000416	0.0207	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—DHFR—bone cancer	0.000386	0.0184	CbGpPWpGaD
Leucovorin—Sensitisation—Doxorubicin—bone cancer	0.000385	0.0192	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—BCOR—bone cancer	0.000376	0.0179	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—DHFR—bone cancer	0.000363	0.0173	CbGpPWpGaD
Leucovorin—Infection—Carboplatin—bone cancer	0.000349	0.0174	CcSEcCtD
Leucovorin—Methotrexate—DHFR—bone cancer	0.000345	0.133	CrCbGaD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000336	0.016	CbGpPWpGaD
Leucovorin—Extravasation—Cisplatin—bone cancer	0.000331	0.0165	CcSEcCtD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00032	0.0152	CbGpPWpGaD
Leucovorin—Kidney function abnormal—Epirubicin—bone cancer	0.000307	0.0153	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000304	0.0144	CbGpPWpGaD
Leucovorin—Kidney function abnormal—Doxorubicin—bone cancer	0.000284	0.0142	CcSEcCtD
Leucovorin—Wheezing—Cisplatin—bone cancer	0.000281	0.014	CcSEcCtD
Leucovorin—Body temperature increased—Carboplatin—bone cancer	0.000278	0.0139	CcSEcCtD
Leucovorin—Neuropathy—Cisplatin—bone cancer	0.000271	0.0135	CcSEcCtD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000266	0.0127	CbGpPWpGaD
Leucovorin—Febrile neutropenia—Methotrexate—bone cancer	0.000264	0.0131	CcSEcCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000253	0.0121	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—DHFR—bone cancer	0.000247	0.0118	CbGpPWpGaD
Leucovorin—Febrile neutropenia—Epirubicin—bone cancer	0.000247	0.0123	CcSEcCtD
Leucovorin—Serum creatinine increased—Epirubicin—bone cancer	0.000241	0.012	CcSEcCtD
Leucovorin—Febrile neutropenia—Doxorubicin—bone cancer	0.000228	0.0114	CcSEcCtD
Leucovorin—Renal failure acute—Cisplatin—bone cancer	0.000227	0.0113	CcSEcCtD
Leucovorin—Serum creatinine increased—Doxorubicin—bone cancer	0.000223	0.0111	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Cisplatin—bone cancer	0.000217	0.0108	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000215	0.0102	CbGpPWpGaD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—RB1—bone cancer	0.000213	0.0101	CbGpPWpGaD
Leucovorin—Blood creatinine increased—Cisplatin—bone cancer	0.000197	0.0098	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—SPARC—bone cancer	0.000183	0.0087	CbGpPWpGaD
Leucovorin—Rigors—Epirubicin—bone cancer	0.000182	0.00906	CcSEcCtD
Leucovorin—Extravasation—Methotrexate—bone cancer	0.000182	0.00906	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—DHFR—bone cancer	0.00018	0.00854	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000174	0.00828	CbGpPWpGaD
Leucovorin—Extravasation—Epirubicin—bone cancer	0.00017	0.00848	CcSEcCtD
Leucovorin—Rigors—Doxorubicin—bone cancer	0.000168	0.00838	CcSEcCtD
Leucovorin—Neuropathy peripheral—Cisplatin—bone cancer	0.000158	0.0079	CcSEcCtD
Leucovorin—Stomatitis—Cisplatin—bone cancer	0.000158	0.00786	CcSEcCtD
Leucovorin—Extravasation—Doxorubicin—bone cancer	0.000157	0.00785	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000151	0.00719	CbGpPWpGaD
Leucovorin—Neuropathy—Epirubicin—bone cancer	0.000139	0.00695	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000138	0.00655	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—PLAU—bone cancer	0.000137	0.00654	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—ZW10—bone cancer	0.00013	0.00619	CbGpPWpGaD
Leucovorin—Neuropathy—Doxorubicin—bone cancer	0.000129	0.00643	CcSEcCtD
Leucovorin—Alopecia—Cisplatin—bone cancer	0.000128	0.00639	CcSEcCtD
Leucovorin—Erythema—Cisplatin—bone cancer	0.000126	0.0063	CcSEcCtD
Leucovorin—Renal failure acute—Methotrexate—bone cancer	0.000125	0.00622	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Methotrexate—bone cancer	0.000119	0.00593	CcSEcCtD
Leucovorin—Lethargy—Methotrexate—bone cancer	0.000117	0.00586	CcSEcCtD
Leucovorin—Ill-defined disorder—Cisplatin—bone cancer	0.000117	0.00584	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000117	0.00557	CbGpPWpGaD
Leucovorin—Renal failure acute—Epirubicin—bone cancer	0.000117	0.00582	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—ZW10—bone cancer	0.000116	0.00554	CbGpPWpGaD
Leucovorin—Malaise—Cisplatin—bone cancer	0.000114	0.00568	CcSEcCtD
Leucovorin—Renal impairment—Epirubicin—bone cancer	0.000113	0.00564	CcSEcCtD
Leucovorin—Leukopenia—Cisplatin—bone cancer	0.000113	0.00564	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—RB1—bone cancer	0.000113	0.00537	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000113	0.00537	CbGpPWpGaD
Leucovorin—Anaphylactoid reaction—Epirubicin—bone cancer	0.000111	0.00555	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—bone cancer	0.00011	0.00548	CcSEcCtD
Leucovorin—Convulsion—Cisplatin—bone cancer	0.000109	0.00546	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—bone cancer	0.000108	0.00538	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000107	0.00507	CbGpPWpGaD
Leucovorin—Discomfort—Cisplatin—bone cancer	0.000106	0.0053	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—bone cancer	0.000105	0.00522	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—bone cancer	0.000104	0.00496	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Cisplatin—bone cancer	0.000103	0.00514	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000103	0.00513	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—GNA11—bone cancer	0.000103	0.00489	CbGpPWpGaD
Leucovorin—Infection—Cisplatin—bone cancer	0.000102	0.00511	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—EZH2—bone cancer	0.000102	0.00487	CbGpPWpGaD
Leucovorin—Lethargy—Doxorubicin—bone cancer	0.000102	0.00507	CcSEcCtD
Leucovorin—Thrombocytopenia—Cisplatin—bone cancer	0.000101	0.00503	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—bone cancer	0.000101	0.00503	CcSEcCtD
Leucovorin—Skin disorder—Cisplatin—bone cancer	0.0001	0.00499	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—TUBB4B—bone cancer	9.87e-05	0.00469	CbGpPWpGaD
Leucovorin—Abdominal pain upper—Epirubicin—bone cancer	9.84e-05	0.0049	CcSEcCtD
Leucovorin—Anorexia—Cisplatin—bone cancer	9.83e-05	0.0049	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RB1—bone cancer	9.82e-05	0.00467	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.71e-05	0.00462	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.58e-05	0.00456	CbGpPWpGaD
Leucovorin—Blood creatinine increased—Doxorubicin—bone cancer	9.34e-05	0.00465	CcSEcCtD
Leucovorin—Dyspnoea—Cisplatin—bone cancer	9.19e-05	0.00458	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—bone cancer	9.11e-05	0.00454	CcSEcCtD
Leucovorin—Decreased appetite—Cisplatin—bone cancer	8.96e-05	0.00447	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—RFC1—bone cancer	8.95e-05	0.00426	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Cisplatin—bone cancer	8.9e-05	0.00444	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—TUBB4B—bone cancer	8.83e-05	0.0042	CbGpPWpGaD
Leucovorin—Stomatitis—Methotrexate—bone cancer	8.65e-05	0.00431	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—bone cancer	8.64e-05	0.00411	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—GSTP1—bone cancer	8.52e-05	0.00405	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—TGFBR2—bone cancer	8.52e-05	0.00405	CbGpPWpGaD
Leucovorin—Feeling abnormal—Cisplatin—bone cancer	8.5e-05	0.00424	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	8.37e-05	0.00398	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—RB1—bone cancer	8.2e-05	0.0039	CbGpPWpGaD
Leucovorin—Body temperature increased—Cisplatin—bone cancer	8.15e-05	0.00406	CcSEcCtD
Leucovorin—Neuropathy peripheral—Epirubicin—bone cancer	8.14e-05	0.00406	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	8.12e-05	0.00386	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.12e-05	0.00386	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	8.11e-05	0.00386	CbGpPWpGaD
Leucovorin—Stomatitis—Epirubicin—bone cancer	8.09e-05	0.00403	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—TGFBR2—bone cancer	8.01e-05	0.00381	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—GSTP1—bone cancer	8.01e-05	0.00381	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—RFC1—bone cancer	8e-05	0.00381	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDK4—bone cancer	7.95e-05	0.00378	CbGpPWpGaD
Leucovorin—Hypersensitivity—Cisplatin—bone cancer	7.6e-05	0.00379	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—bone cancer	7.53e-05	0.00375	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—bone cancer	7.49e-05	0.00373	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	7.42e-05	0.00353	CbGpPWpGaD
Leucovorin—Asthenia—Cisplatin—bone cancer	7.4e-05	0.00369	CcSEcCtD
Leucovorin—Chills—Methotrexate—bone cancer	7.15e-05	0.00356	CcSEcCtD
Leucovorin—Diarrhoea—Cisplatin—bone cancer	7.06e-05	0.00352	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—bone cancer	7.04e-05	0.00351	CcSEcCtD
Leucovorin—Erythema—Methotrexate—bone cancer	6.93e-05	0.00346	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—RB1—bone cancer	6.91e-05	0.00329	CbGpPWpGaD
Leucovorin—Dysgeusia—Methotrexate—bone cancer	6.79e-05	0.00338	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	6.76e-05	0.00321	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—GSTP1—bone cancer	6.76e-05	0.00321	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	6.72e-05	0.0032	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.7e-05	0.00319	CbGpPWpGaD
Leucovorin—Chills—Epirubicin—bone cancer	6.69e-05	0.00333	CcSEcCtD
Leucovorin—Alopecia—Epirubicin—bone cancer	6.59e-05	0.00328	CcSEcCtD
Leucovorin—Vomiting—Cisplatin—bone cancer	6.56e-05	0.00327	CcSEcCtD
Leucovorin—Rash—Cisplatin—bone cancer	6.5e-05	0.00324	CcSEcCtD
Leucovorin—Dermatitis—Cisplatin—bone cancer	6.5e-05	0.00324	CcSEcCtD
Leucovorin—Erythema—Epirubicin—bone cancer	6.49e-05	0.00323	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—bone cancer	6.43e-05	0.00321	CcSEcCtD
Leucovorin—Dysgeusia—Epirubicin—bone cancer	6.35e-05	0.00317	CcSEcCtD
Leucovorin—TYMS—Metabolism—NDUFA12—bone cancer	6.33e-05	0.00301	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.3e-05	0.003	CbGpPWpGaD
Leucovorin—Malaise—Methotrexate—bone cancer	6.25e-05	0.00312	CcSEcCtD
Leucovorin—Leukopenia—Methotrexate—bone cancer	6.21e-05	0.00309	CcSEcCtD
Leucovorin—Chills—Doxorubicin—bone cancer	6.19e-05	0.00308	CcSEcCtD
Leucovorin—Nausea—Cisplatin—bone cancer	6.13e-05	0.00305	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—bone cancer	6.09e-05	0.00304	CcSEcCtD
Leucovorin—Ill-defined disorder—Epirubicin—bone cancer	6.02e-05	0.003	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.02e-05	0.00286	CbGpPWpGaD
Leucovorin—Convulsion—Methotrexate—bone cancer	6.01e-05	0.00299	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—bone cancer	6e-05	0.00299	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—bone cancer	5.88e-05	0.00293	CcSEcCtD
Leucovorin—Malaise—Epirubicin—bone cancer	5.85e-05	0.00292	CcSEcCtD
Leucovorin—Discomfort—Methotrexate—bone cancer	5.83e-05	0.00291	CcSEcCtD
Leucovorin—Syncope—Epirubicin—bone cancer	5.82e-05	0.0029	CcSEcCtD
Leucovorin—Leukopenia—Epirubicin—bone cancer	5.81e-05	0.00289	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.78e-05	0.00275	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—CDK4—bone cancer	5.78e-05	0.00275	CbGpPWpGaD
Leucovorin—Confusional state—Methotrexate—bone cancer	5.71e-05	0.00284	CcSEcCtD
Leucovorin—Loss of consciousness—Epirubicin—bone cancer	5.7e-05	0.00284	CcSEcCtD
Leucovorin—Anaphylactic shock—Methotrexate—bone cancer	5.66e-05	0.00282	CcSEcCtD
Leucovorin—Convulsion—Epirubicin—bone cancer	5.62e-05	0.0028	CcSEcCtD
Leucovorin—Infection—Methotrexate—bone cancer	5.62e-05	0.0028	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—bone cancer	5.57e-05	0.00278	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—DHFR—bone cancer	5.55e-05	0.00264	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Methotrexate—bone cancer	5.54e-05	0.00276	CcSEcCtD
Leucovorin—Skin disorder—Methotrexate—bone cancer	5.5e-05	0.00274	CcSEcCtD
Leucovorin—Discomfort—Epirubicin—bone cancer	5.46e-05	0.00272	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.44e-05	0.00259	CbGpPWpGaD
Leucovorin—Malaise—Doxorubicin—bone cancer	5.41e-05	0.0027	CcSEcCtD
Leucovorin—Anorexia—Methotrexate—bone cancer	5.39e-05	0.00269	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—bone cancer	5.38e-05	0.00268	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—bone cancer	5.37e-05	0.00268	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—bone cancer	5.34e-05	0.00266	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.31e-05	0.00253	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Epirubicin—bone cancer	5.3e-05	0.00264	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—bone cancer	5.28e-05	0.00263	CcSEcCtD
Leucovorin—Infection—Epirubicin—bone cancer	5.26e-05	0.00262	CcSEcCtD
Leucovorin—TYMS—Metabolism—NT5C3A—bone cancer	5.24e-05	0.00249	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NDUFA12—bone cancer	5.24e-05	0.00249	CbGpPWpGaD
Leucovorin—Shock—Epirubicin—bone cancer	5.21e-05	0.0026	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—bone cancer	5.2e-05	0.00259	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—bone cancer	5.18e-05	0.00258	CcSEcCtD
Leucovorin—Skin disorder—Epirubicin—bone cancer	5.14e-05	0.00256	CcSEcCtD
Leucovorin—Discomfort—Doxorubicin—bone cancer	5.05e-05	0.00252	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—bone cancer	5.05e-05	0.00252	CcSEcCtD
Leucovorin—Dyspnoea—Methotrexate—bone cancer	5.04e-05	0.00251	CcSEcCtD
Leucovorin—Dyspepsia—Methotrexate—bone cancer	4.98e-05	0.00248	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—DHFR—bone cancer	4.96e-05	0.00236	CbGpPWpGaD
Leucovorin—Confusional state—Doxorubicin—bone cancer	4.94e-05	0.00246	CcSEcCtD
Leucovorin—Decreased appetite—Methotrexate—bone cancer	4.92e-05	0.00245	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—bone cancer	4.9e-05	0.00244	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—bone cancer	4.89e-05	0.00243	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—bone cancer	4.88e-05	0.00243	CcSEcCtD
Leucovorin—Infection—Doxorubicin—bone cancer	4.87e-05	0.00243	CcSEcCtD
Leucovorin—Shock—Doxorubicin—bone cancer	4.82e-05	0.0024	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—bone cancer	4.8e-05	0.00228	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Doxorubicin—bone cancer	4.8e-05	0.00239	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—bone cancer	4.76e-05	0.00237	CcSEcCtD
Leucovorin—Dyspnoea—Epirubicin—bone cancer	4.72e-05	0.00235	CcSEcCtD
Leucovorin—Anorexia—Doxorubicin—bone cancer	4.67e-05	0.00233	CcSEcCtD
Leucovorin—Feeling abnormal—Methotrexate—bone cancer	4.66e-05	0.00232	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—bone cancer	4.66e-05	0.00232	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methotrexate—bone cancer	4.63e-05	0.00231	CcSEcCtD
Leucovorin—Decreased appetite—Epirubicin—bone cancer	4.6e-05	0.00229	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.59e-05	0.00218	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Epirubicin—bone cancer	4.57e-05	0.00228	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—bone cancer	4.57e-05	0.00228	CcSEcCtD
Leucovorin—Constipation—Epirubicin—bone cancer	4.53e-05	0.00226	CcSEcCtD
Leucovorin—Urticaria—Methotrexate—bone cancer	4.5e-05	0.00224	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—bone cancer	4.47e-05	0.00223	CcSEcCtD
Leucovorin—Body temperature increased—Methotrexate—bone cancer	4.47e-05	0.00223	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.46e-05	0.00212	CbGpPWpGaD
Leucovorin—Dyspnoea—Doxorubicin—bone cancer	4.37e-05	0.00218	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—bone cancer	4.36e-05	0.00218	CcSEcCtD
Leucovorin—ABCC3—Metabolism—NT5C3A—bone cancer	4.34e-05	0.00206	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Epirubicin—bone cancer	4.33e-05	0.00216	CcSEcCtD
Leucovorin—Dyspepsia—Doxorubicin—bone cancer	4.31e-05	0.00215	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.3e-05	0.00205	CbGpPWpGaD
Leucovorin—Decreased appetite—Doxorubicin—bone cancer	4.26e-05	0.00212	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—bone cancer	4.23e-05	0.00211	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—bone cancer	4.22e-05	0.00211	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—bone cancer	4.21e-05	0.0021	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—bone cancer	4.19e-05	0.00209	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—bone cancer	4.19e-05	0.00209	CcSEcCtD
Leucovorin—Body temperature increased—Epirubicin—bone cancer	4.19e-05	0.00209	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—SPARC—bone cancer	4.18e-05	0.00199	CbGpPWpGaD
Leucovorin—Hypersensitivity—Methotrexate—bone cancer	4.17e-05	0.00208	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—CHEK2—bone cancer	4.15e-05	0.00197	CbGpPWpGaD
Leucovorin—Asthenia—Methotrexate—bone cancer	4.06e-05	0.00202	CcSEcCtD
Leucovorin—Feeling abnormal—Doxorubicin—bone cancer	4.04e-05	0.00201	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—bone cancer	4.01e-05	0.002	CcSEcCtD
Leucovorin—Pruritus—Methotrexate—bone cancer	4e-05	0.002	CcSEcCtD
Leucovorin—Hypersensitivity—Epirubicin—bone cancer	3.9e-05	0.00194	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—bone cancer	3.89e-05	0.00194	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.88e-05	0.00185	CbGpPWpGaD
Leucovorin—Body temperature increased—Doxorubicin—bone cancer	3.87e-05	0.00193	CcSEcCtD
Leucovorin—Abdominal pain—Doxorubicin—bone cancer	3.87e-05	0.00193	CcSEcCtD
Leucovorin—Diarrhoea—Methotrexate—bone cancer	3.87e-05	0.00193	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—GNA11—bone cancer	3.82e-05	0.00182	CbGpPWpGaD
Leucovorin—Asthenia—Epirubicin—bone cancer	3.8e-05	0.00189	CcSEcCtD
Leucovorin—Pruritus—Epirubicin—bone cancer	3.75e-05	0.00187	CcSEcCtD
Leucovorin—Dizziness—Methotrexate—bone cancer	3.74e-05	0.00187	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—JUN—bone cancer	3.72e-05	0.00177	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—bone cancer	3.62e-05	0.00181	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—bone cancer	3.61e-05	0.0018	CcSEcCtD
Leucovorin—Vomiting—Methotrexate—bone cancer	3.6e-05	0.00179	CcSEcCtD
Leucovorin—Rash—Methotrexate—bone cancer	3.57e-05	0.00178	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—bone cancer	3.56e-05	0.00178	CcSEcCtD
Leucovorin—Asthenia—Doxorubicin—bone cancer	3.52e-05	0.00175	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—BRCA2—bone cancer	3.51e-05	0.00167	CbGpPWpGaD
Leucovorin—Dizziness—Epirubicin—bone cancer	3.5e-05	0.00175	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—bone cancer	3.47e-05	0.00173	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—IL3—bone cancer	3.47e-05	0.00165	CbGpPWpGaD
Leucovorin—Vomiting—Epirubicin—bone cancer	3.37e-05	0.00168	CcSEcCtD
Leucovorin—Nausea—Methotrexate—bone cancer	3.36e-05	0.00168	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—bone cancer	3.35e-05	0.00167	CcSEcCtD
Leucovorin—Rash—Epirubicin—bone cancer	3.34e-05	0.00166	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—bone cancer	3.34e-05	0.00166	CcSEcCtD
Leucovorin—Dizziness—Doxorubicin—bone cancer	3.24e-05	0.00161	CcSEcCtD
Leucovorin—Nausea—Epirubicin—bone cancer	3.15e-05	0.00157	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—bone cancer	3.12e-05	0.00155	CcSEcCtD
Leucovorin—Rash—Doxorubicin—bone cancer	3.09e-05	0.00154	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—bone cancer	3.09e-05	0.00154	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.05e-05	0.00145	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDK4—bone cancer	2.91e-05	0.00139	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—bone cancer	2.91e-05	0.00145	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—CDK4—bone cancer	2.61e-05	0.00124	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.56e-05	0.00122	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—RB1—bone cancer	2.53e-05	0.00121	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—bone cancer	2.46e-05	0.00117	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ENO2—bone cancer	2.3e-05	0.00109	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PLAU—bone cancer	2.27e-05	0.00108	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—RB1—bone cancer	2.27e-05	0.00108	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—DHFR—bone cancer	2.13e-05	0.00101	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GNA11—bone cancer	1.99e-05	0.000947	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MDM2—bone cancer	1.93e-05	0.000919	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ENO2—bone cancer	1.9e-05	0.000904	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP3A4—bone cancer	1.81e-05	0.000859	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—DHFR—bone cancer	1.76e-05	0.000839	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GNA11—bone cancer	1.65e-05	0.000784	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTP1—bone cancer	1.54e-05	0.000735	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP3A4—bone cancer	1.49e-05	0.000711	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.49e-05	0.000707	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTP1—bone cancer	1.28e-05	0.000608	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—bone cancer	1.11e-05	0.000527	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—bone cancer	9.14e-06	0.000435	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS2—bone cancer	8e-06	0.000381	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS2—bone cancer	6.62e-06	0.000315	CbGpPWpGaD
